Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marie-Pier Cloutier"'
Autor:
Jugurtha Ouboudinar, Ramon Corpuz, Martin Leduc, Jean-Simon Duceppe, Alexandre Laverdure, Mikaël Tremblay, Kathy Hince, Amélie Blais, Marie-Pier Cloutier, Richard L. Hébert, Christopher R.J. Kennedy, Alexandra Blais, Liette Gervais, Lilianne Geerts, Lyne Gagnon, Pierre Laurin, Jean-Christophe Simard, Steven R. LaPlante, Sylvie Létourneau, Jean-Francois Thibodeau, François A. Leblond, Brigitte Grouix, Shaun D. Abbott, Boulos Zacharie, Alexandra Felton, Vanessa Marques Quintela, William Gagnon, François Sarra-Bournet
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
Non-alcoholic Fatty Liver Disease (NAFLD) is the most common form of liver disease and is associated with metabolic dysregulation. Although G protein-coupled receptor 84 (GPR84) has been associated with inflammation, its role in metabolic regulation
Autor:
Jean-Francois Thibodeau, Alexandre Laverdure, Kathy Hince, Richard L. Hébert, Alex Gutsol, William Gagnon, Martin Leduc, Eldjonai Kamto, Liette Gervais, Shaun D. Abbott, Christopher R.J. Kennedy, Francois A. Leblond, Jonathan Richard, Pierre Laurin, Chet E. Holterman, Alexandra Felton, Ming-Zhi Zhang, François Sarra-Bournet, Mikaël Tremblay, Jugurtha Ouboudinar, Lilianne Geerts, Christopher Penney, Lyne Gagnon, Jocelyn Dupuis, Jean-Christophe Simard, Jean-Simon Duceppe, Quang Trinh Nguyen, Marie-Pier Cloutier, Raymond C. Harris, Angelino Calderone, Brigitte Grouix, Boulos Zacharie, Sylvie Létourneau
Publikováno v:
The American Journal of Pathology. 188:1132-1148
Numerous clinical conditions can lead to organ fibrosis and functional failure. There is a great need for therapies that could effectively target pathophysiological pathways involved in fibrosis. GPR40 and GPR84 are G protein–coupled receptors with
Autor:
Jonathan Richard, Lyne Gagnon, Jean-Christophe Simard, Brigitte Grouix, Liette Gervais, Pierre Laurin, Alexandre Laverdure, Marie-Pier Cloutier, Alexandra Felton
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Chris R. J. Kennedy, Marie-Pier Cloutier, François A. Leblond, Pierre Laurin, Jean-Francois Thibodeau, Chet E. Holterman, Lyne Gagnon, Jean-Christophe Simard, Richard L. Hébert
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Chet E. Holterman, Marie-Pier Cloutier, Lyne Gagnon, Jean-Christophe Simard, Amélie Blais, Richard L. Hébert, Jean-Francois Thibodeau, Francois A. Leblond, Brigitte Grouix, Thalia Medeiros, Martin Leduc, Dylan Burger, Christopher R.J. Kennedy
Publikováno v:
Clinical science (London, England : 1979). 133(14)
PBI-4050 (3-pentylbenzenacetic acid sodium salt), a novel first-in-class orally active compound that has completed clinical Phases Ib and II in subjects with chronic kidney disease (CKD) and metabolic syndrome respectively, exerts antifibrotic effect
Autor:
Marie-Pier Cloutier, François A. Leblond, Brigitte Grouix, Alexandre Laverdure, Mikaël Tremblay, Jonathan Richard, Liette Gervais, François Sarra-Bournet, Pierre Laurin, Alexandra Felton, Lyne Gagnon
Publikováno v:
Diabetes. 67
Introduction and Aims: Given the expected rise in the prevalence of obesity and type 2 diabetes, hepatic steatosis will, if not already, become an epidemic. The aim of this study was to determine the mechanism of action of PBI-4547 on diabetic compli
Autor:
Alexandre Laverdure, Jonathan Richard, Marie-Pier Cloutier, Lyne Gagnon, Liette Gervais, Jean-Christophe Simard, Pierre Laurin, François A. Leblond, Brigitte Grouix, Alexandra Felton, Martin Leduc
Publikováno v:
Diabetes. 67
Background: PBI-4050 displays anti-inflammatory/fibrotic properties with metabolic regulation. PBI-4050 has been shown to reduce glycated hemoglobin levels, and different biomarkers related to kidney and heart injury in a phase II open label clinical
Autor:
Mikaël Tremblay, William Gagnon, Martin Leduc, Marie-Pier Cloutier, Lyne Gagnon, François A. Leblond, Brigitte Grouix, François Sarra-Bournet, Jean-Christophe Simard, Pierre Laurin, Kathy Hince, Sylvie Létourneau
Publikováno v:
Diabetes. 67
Introduction: PBI-4547 is a novel orally active compound that is being developed for potential clinical use in patients suffering from metabolic and inflammatory/fibrosis-related diseases. This study examined the effect of PBI-4547 in NOD mice, a mod
Autor:
Alexandre Laverdure, Marie-Pier Cloutier, Jonathan Richard, Alexandra Felton, Mikaël Tremblay, Brigitte Grouix, Liette Gervais, Lyne Gagnon, Pierre Laurin, François Sarra-Bournet
Publikováno v:
Journal of Hepatology. 70:e86-e87
Autor:
Lilianne Geerts, François Sarra-Bournet, Pierre Laurin, Marie-Pier Cloutier, Brigitte Grouix, Alexandra Felton, Mikaël Tremblay, Lyne Gagnon
Publikováno v:
Diffuse Parenchymal Lung Disease.